Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 43063-790

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 43063-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063790 Label (43063790)

This is a medication called Oxybutynin Chloride ER USP, which comes in 10 mg and has 90 tablets in a bottle. It is important not to consume alcohol or alcoholic beverages while using this medication, as it may cause drowsiness. Children should not have access to this medication. The dosage and storage information can be found in the package insert. It is recommended to contact a doctor if any side effects occur, and side effects can also be reported to FDA. Each tablet contains extended-release 10mg oxybutynin chloride. The rest of the text appears to be not-readable.*

FDA Label Image

Oxybutynin Chloride Extended Release 1

FDA Label Image

Oxybutynin Chloride Extended Release 2

This is a table showing the mean plasma concentration of R-Oxybutynin in ng/mL over time for two different formulations of the drug: oxybutynin chloride extended-release tablets 10mg and oxybutynin 5mg taken three times a day.*

FDA Label Image

Oxybutynin Chloride Extended Release 3

FDA Label Image

Oxybutynin Chloride Extended Release 4

FDA Label Image

Oxybutynin Chloride Extended Release 5

FDA Label Image

Oxybutynin Chloride Extended Release 6

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.